JD Health grants shares to employees for retention and growth

JD Health International Inc. announced a grant of 299,090 Award Shares to employees, excluding directors and senior management, on October 1, 2025, under its Post-IPO Share Award Scheme. These new shares represent approximately 0.01% of the total issued shares as of the grant date. The market price of the shares on the grant date was HK$66.500 per share. The purpose of these grants is to align employee interests with the group's performance and to encourage retention and contributions to the company's sustained growth and profitability.

The awarded shares will vest over varying periods: 47,510 Award Shares will vest over 0.25 to 3.25 years, while 251,580 Award Shares will vest over 1 to 4 years from the grant date. A smaller batch of 7,126 Award Shares has a shorter vesting period of less than 12 months due to administrative batching. No performance targets are attached to these grants.

The total number of shares available for future grant under the scheme's mandate limit, after this grant, is 244,584,254. The company clarified that this grant will not cause any individual grantee to exceed 1% of the shares in issue over a 12-month period, nor does it require shareholder approval, as no directors, chief executives, or substantial shareholders are among the grantees.